Why CRISPR Therapeutics Stock Fell 25.2% in July
Shares of CRISPR Therapeutics (NASDAQ: CRSP) lost 25.2% of their value in July, according to data from S&P Global…
Shares of CRISPR Therapeutics (NASDAQ: CRSP) lost 25.2% of their value in July, according to data from S&P Global…
Start Time: 08:30 January 1, 0000 9:29 AM ETFluor Corporation (NYSE:FLR)Q2 2021 Earnings Conference CallAugust 06, 2021, 08:30…
Is NVAX stock a buy or a sell after crumbling on another delay for its Covid vaccine? Here’s what…
The video software company’s earnings came in below expectations.
Daniel Loeb’s hedge fund, Third Point, told investors on Friday that it made a new bet on upscale home…
Stocks, cryptocurrencies, and other collectibles have nothing on Rolex, if secondary market pricing on 2021 models is any indication….
The classic mix of stocks and bonds may be a relic of an age long past.
SS&C trading at a wide discount to the index. Over 90% of recurring revenues. Over 95% of retention rate.
ST. PAUL, Minn., Aug. 6, 2021 /PRNewswire/ — Today, St. Paul-based AgriBank announced financial results for the second quarter…
Interest in investing has become more popular lately—but could the resurgence of these clubs be a sign of a…